Back to Search
Start Over
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients.
- Source :
- Journal of Translational Medicine; 9/8/2022, Vol. 20 Issue 1, p1-3, 3p
- Publication Year :
- 2022
-
Abstract
- Keywords: COVID-19; CXCL9; Cytokine; Dexamethasone; Inflammation; Serology EN COVID-19 CXCL9 Cytokine Dexamethasone Inflammation Serology 1 3 3 09/12/22 20220908 NES 220908 Supplementary Information The online version contains supplementary material available at https://doi.org/10.1186/s12967-022-03583-5. " I" or " C" refers to analytes measured by Olink Inflammation I panel or Cardiovascular II panel, respectively Focusing on markers differentially regulated in COVID-19 patients, we observed a unique biomarker profile in patients depending on their therapeutic journey. 1 A (lower) Heatmap analysis comparing fold change for protein biomarker levels in baseline samples of COVID-19 patients versus age/sex-matched healthy controls (HC). [Extracted from the article]
- Subjects :
- COVID-19
STEROID drugs
SEROLOGY
MEDICAL personnel
BIOMARKERS
FERRITIN
Subjects
Details
- Language :
- English
- ISSN :
- 14795876
- Volume :
- 20
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Journal of Translational Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 158998386
- Full Text :
- https://doi.org/10.1186/s12967-022-03583-5